2013年SCI论文
发布时间：2015-01-26
【字号：小中大 】
浏览次数：
- Li W, Gao Z, Yang C, et al. The estimation of prevalence, incidence, and residual risk of transfusion-transmitted human hepatitis B infection from blood donated at the Anhui blood center, China, from 2009 to 2011. PloS one. 2013;8:e73472.
- Yuan Y, Yokoyama M, Maeda Y, Terasawa H, Harada S, Sato H, Yusa K*, Structure and dynamics of the gp120 V3 loop that confers noncompetitive resistance in R5 HIV-1(JR-FL) to maraviroc. PLoS One. 2013,8(6):e65115.
- L. Chen*, S. Li, Y. Li, X. Duan, B. Liu, and I. McGilvray. Ubiquitin-like protein modifiers and their potential for antiviral and anti-HCV therapy. Expert Rev Proteomics. 2013; 10(3):275-287.
- Liu, Y., Ma, H., Chen, S., Wang, J., Liu, G., Xu, M., Ke, L., He, M. Interleukin-28B genetic variations and spontaneous clearance of hepatitis C antibody-positive blood donors in China. Transfusion. 2013; 53(10 Pt 2): 2498-2504.
- Li, Zhongmin Zhou, Weilan He, Tonghan Yang, Fuzhu Yao, Xiangming Zhu, Guoxin Wen, Xinhong Bi, Mei-hei-li Tiemuer, Xiuqiong Wen, Mei Huang, Ru’an Cao, Zhongqiao Yun, Yunlai Lv, Hongli Ma, Nan Guo, Qilu Yu, Paul Ness, and Hua Shan. The persistence of hepatitis C virus transmission risk in China despite serologic screening of blood donations. Transfusion. 2013; 53 (10 Pt 2):2489-2497.
- Jingxing Wang, Jing Liu, Fuzhu Yao, Guoxin Wen, Julin Li, Yi Huang, Yunlai Lv, Xiuqiong Wen, David Wright, Qilu Yu, Nan Guo, Paul Ness, and Hu Shan. Prevalence, incidence, and residual risks for transfusion-transmitted human immunodeficiency virus Types 1 and 2 infection among Chinese blood donors. Transfusion. 2013; 53 (6):1240-1249.
- Jingxing Wang, Jing Liu, Yi Huang, Tonghan Yang, Fuzhu Yao, Xiangdong Dong, Guoxin Wen, Xinhong Bi, Minjiang Zhao, Xiuqiong Wen, Mei Huang, Yunlai Lv, Hongli Ma, Qilu Yu, David Wright, Nan Guo, Paul Ness, and Hua Shan. An analysis of risk factors for human immunodeficiency virus infection among Chinese blood donors. Transfusion. 2013; 53 (10 Pt 2):2431-2440.
- Wang J, Xia L, Luo M, Chen Q. A novel HLA-C allele, HLA-C*06:45, identified by sequence-based typing in a Chinese individual. Tissue Antigens. 2013; 82: 67-68.
- Ma L, Sun P, Lin F, et al. In vitro evaluation of residual procoagulants in human intravenous immunoglobulins from 11 Chinese blood fractionation companies. Thrombosis research. 2013, 132(3): 381-385.
- Zhong R, Wang H, Wu X, et al. In vitro investigation of the effect of plasticizers on the blood compatibility of medical grade plasticized poly (vinyl chloride)[J]. Journal of Materials Science: Materials in Medicine. 2013, 24(8): 1985-1992.
- Zhou, X., Liu, Z., Liang, X.M., Shu, Z., Du, P., Gao, D. Theoretical investigations of a novel microfluidic cooling/warming system for cell vitrification cryopreservation. International Journal of Heat and Mass Transfer. 2013, 65:381-388.
- Zeng, Y. Liu, M. He, Z. Gao, Y. Zhou, G. Bian, H. Shan, and J. Wang*. HIV-1 genotypic diversity and prevalence of drug resistance among treatment naive HIV-infected individuals in Chengdu of China. Virus Genes.2013; 47(3): 408- 413.
- Zhang X, Ye S, Du X, et al. Chinese plasma-derived products supply under the lot release management system in 2007–2011[J]. Biologicals. 2013, 41(6): 364-367.
- Zhang R, Xiao J, Lin J, et al. Plasma transfusion in two disasters: experience from earthquake and bus burning incident in China[J]. Transfusion Medicine. 2013, 23(4): 279-280.
- Tian L, Yao ZQ, Deng YF, Hong L, Song N.A novel A allele with the 595 C>T mutation identified in a Chinese individual with the Am phenotype. Transfus Med. 2013 Apr;23(2):134-135.
- GuoHui Bian, Chunhui Yang, Miao He, Hong Wang, Jiaxin Liu, Ye Cao, Hong Yang, Zhong Liu, and Wuping Li. Three different bacterial detection systems for platelet concentrates under inter-laboratory conditions. Transfus Apher Sci. 2013; 49 (3):600-607.
- Y. Chunhui, B. Guohui, Y. Hong, X. Xiaopu, B. Zherong, W. Mingyuan, Z. Xinsheng, W. Juanjuan, L. Changqing, and L. Wuping*. Quantitative evaluation of plasma after methylene blue and white light treatment in four Chinese blood centers. Transfus Apher Sci. 2013; 49(3):631-639.
- Wei Xiao∗, Changqing Li, XiaoPu. Xiao, Fangzhao Lin∗.Expression and fast preparation of biologically active recombinant human coagulation factor VII in CHO-K1 cells. Genetics and Molecular Research. 2013;12 (4):6813-6824.
- Ma L, Sun P, Lin F Z, et al. Quantitative determination of activated coagulation factor XI as an impurity in therapeutic immunoglobulins from Chinese blood fractionation companies[J]. Genetics and Molecular Research. 2013, 12(3): 2556-2561.
- Zhou W, Zhao L, Wang J, et al. An optimal polymerization conditions for poly-human placenta hemoglobin with lower mean molecular weight[J]. Artificial Cells, Nanomedicine, and Biotechnology. 2013, 41(5): 289-292.
- Huang Y, Cao H*, Lin Y, et al. Adsorption of phenol with the crosslinked polymer of P (MMA-MAh)-PEG33[J]. Desalination and Water Treatment. 2013, 51(34-36): 6755-6760.
- Mingjun Wu,Qiang Chen,Wu Wei,Zhongwei Zheng. Fluctuating levels of reprogramming factor expression in cultured human undifferentiated keratinocytes. African Journal of Biotechnology. 2013;12(35):538-542.
- B.Liu, S. Li, Y.Li, X. Duan and L. Chen*. High through-put Gene Expression Profiling: Its Application in Studying Transfusion-Transmitted Infections. J Bioanalysis & Biomedicine. 2013;5(1):111-112.
- C.Yang, P. Zeng, Y.Li, S.Li, X.Duan, H.Yang, and Limin Chen*. Last Line to Secure Transfusion Safety: Pathogen Inactivation/Reduction Methods in Blood Products-Current Approaches and Perspectives. J Antivirus and Antiretrovirus. 2013;5(6):137-138.
- L.Yuan, J. Yuan, Y.Li, S.Li, X.Duan, Bi.Liu and L.Chen*. Host Factors to Predict Treatment Response in HCV Patients: Implications for Individualized Therapy and Translational Medicine for HCV Management. J Bioanalysis and Biomedicine. 2013;5(4):121-121.
- Y. Li, S. Li, X. Duan, B.Liu, P. Zeng, C.Yang, and L.Chen*. Modulating Innate Immune Response to Combat Viral Infections-Use HCV as an Example. J Antivirus and Antiretrovirus. 2013;5(3): 107-108.
